Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia. Lichter DG, Hershey L. Neurology 2023 Jul 3:10.1212/WNL.0000000000207498.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lichter DG, Hershey L. Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia. Neurology 2023 Jul 3:10.1212/WNL.0000000000207498.
PMID: 37400241